Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Invites Ventures is a venture capital firm established in November 2019 and headquartered in Seoul, South Korea. The firm operates under a New Technology Venture Capital Business license, known as the 'Shinkisa' license, and is wholly owned by CG Invites, which is listed on KOSDAQ. Initially, Invites Ventures concentrated on biotech investments, particularly in new drug pipelines. However, the firm has since diversified its portfolio to include sectors such as deep tech and personal mobility, seeking high-growth opportunities in artificial intelligence, innovative medical devices, and digital healthcare.
As of now, Invites Ventures manages assets under management (AUM) of approximately $73 to $80 million and has made 20 core investments. The firm has a team of six professionals dedicated to identifying and supporting innovative startups. Invites Ventures has a strong presence not only in Korea but also in the U.S. and Japan, allowing it to tap into cross-border investment opportunities.
Invites Ventures primarily invests in the biotech, deep tech, and personal mobility sectors. The firm is particularly interested in high-growth areas such as artificial intelligence, innovative medical devices, and digital healthcare. It targets various stages of investment, including seed, Series A, Series B, Series C, and growth equity. The firm seeks opportunities in Korea, Japan, and the United States, focusing on innovative companies that demonstrate significant growth potential.
In its investment strategy, Invites Ventures looks for startups that can navigate the complexities of the biotech and tech landscapes. The firm emphasizes the importance of strategic guidance and access to cross-border opportunities, leveraging its extensive network to support portfolio companies. Invites Ventures aims to partner with founders who are committed to innovation and have a clear vision for their companies.
Invites Ventures has made a total of 20 core investments across various sectors. Notable portfolio companies include:
Aiden Lee - CEO. Aiden has a background in venture capital and has led multiple investments in high-growth sectors. He holds a degree from a prestigious university and has experience in both domestic and international markets.
Kyle Kam - Senior Associate. Kyle specializes in analyzing investment opportunities in the biotech and tech sectors. He has a strong analytical background and has worked on several successful deals.
Eden Lee - Analyst. Eden focuses on market research and due diligence for potential investments. She has a keen interest in emerging technologies and startups.
Hyein Lee - Manager. Hyein oversees portfolio management and supports portfolio companies in their growth strategies. She has experience in operational roles within startups.
Yunseon Eom - Assistant Manager. Yunseon assists in deal sourcing and analysis, contributing to the firm's investment strategy.
Seonmin Hwang - Assistant Manager. Seonmin supports the team in various operational tasks and helps maintain relationships with portfolio companies.
To pitch to Invites Ventures, founders should send an email to contact@invitesventures.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. While there is no specific application form, a clear and concise presentation is essential. Response times may vary, but founders can expect to hear back within a few weeks.
In April 2023, Invites Ventures announced its investment in Furiosa AI, a leading Korean AI chip company, highlighting its commitment to deep tech investments. In March 2023, the firm participated in a funding round for IICOMBINED Co., Ltd., further expanding its portfolio in innovative technology solutions. Additionally, Invites Ventures has been actively exploring opportunities in the U.S. market, seeking to enhance its cross-border investment strategy.
What are Invites Ventures' investment criteria?
Invites Ventures primarily invests in biotech, deep tech, and personal mobility sectors. The firm looks for high-growth opportunities in areas such as artificial intelligence, innovative medical devices, and digital healthcare. They target companies at various stages, including seed, Series A, Series B, Series C, and growth equity.
How can I apply or pitch to Invites Ventures?
Founders can pitch to Invites Ventures by sending an email to contact@invitesventures.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Invites Ventures different from other VC firms?
Invites Ventures differentiates itself through its focus on high-growth sectors and its strategic guidance. The firm leverages its network to provide cross-border opportunities, particularly in Korea, Japan, and the U.S., which enhances the growth potential of its portfolio companies.
What is the geographic scope of Invites Ventures?
Invites Ventures has a strong presence in Korea, the U.S., and Japan, allowing it to pursue both domestic and international investment opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, Invites Ventures invests across various stages, indicating a flexible approach to funding based on the needs of the startup.
What kind of post-investment involvement does Invites Ventures have?
Invites Ventures provides strategic guidance and support to its portfolio companies, helping them navigate the complexities of their respective industries. The firm focuses on fostering growth and innovation within its investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.